Maddipati Lab (@MaddipatiLab) profile picture
Dallas, TX
Joined January 2010
Conventional therapies often fail in metastatic pancreatic cancer. @MaddipatiLab @utswcancer reviews tumor-stroma interactions that shape metastatic progression in PDAC and highlight potential stage- and site-specific therapeutic opportunities for intervention: jci.org/articles/view/191943
8
1
29
5,091
Early-stage investigators proposed innovative high-impact research ideas for the @NIHDirector’s New Innovator Award. See the projects the awardees will pursue: commonfund.nih.gov/newinnova… #NIHHighRisk
28
64
123
408
767,095
Maddipati Lab retweeted
Katalin Karikó and Drew Weissman – awarded the 2023 #NobelPrize in Physiology or Medicine – discovered that base-modified mRNA can be used to block activation of inflammatory reactions and increase protein production when mRNA is delivered to cells.
16
761
74
2,131
356,652
"This work has opened the door for a decade’s worth of research." -@timofran1 @umichmedicine & @GiftofLifeMich project shows PanIN lesions more common than previously thought, opening new pathway to understanding progression of pancreatic cancer. ⬇️⬇️⬇️ medicine.umich.edu/dept/surg…
12
1
23
5,142
Pleiotrophin drives a prometastatic immune niche in #BreastCancer, say Debolina Ganguly @debog93, Rolf Brekken @brekkenlab et al @utswcancer @UTSWNews: https://nitter.cf/t.co/kZIscBCcEe @gilbertzmurimwa @FaValdesMora @dgallegoortega #TumorImmunology #metastasis
9
1
30
3,795
Excited to share our latest work highlighting the role of cell competition in shaping metastatic latency and relapse @CD_AACR !! A collaborative effort with @PayalKapur5 @JBrugarolas and @brekkenlab @ElizSMcKenna - Appreciate all the support !!
35
27
2
111
Replying to @aguilera_md
@aguilera_md @NiuSanford @drdavidpalma @Dr_AliHosni @TAMERMR @ldawsonmd @BobTimmermanMD A series of SABR ttt PDAC oligomets (OPanc) (1-5 mets) published in Red Journal. Retro, small n & selection bias limiting, but SABR doubled OS with less time on CTH. authors.elsevier.com/c/1fgzw…
1
11
5
31
Maddipati Lab retweeted
ICYMI: Final version of the @CD_AACR paper on T cell trajectories in pancreatic cancer is now online. Magnum opus from the @MDAndersonNews #PancreaticCancer #Moonshot team. Single cell RNAseq & TCRseq on 80,000 T cells, treasure trove for mining targets! aacrjournals.org/cancerdisco… – at Houston, TX
5
58
1
187
Maddipati Lab retweeted
If you are interested in apCAFs in PDA give this paper from Huocong Huang a read. @utswcancer @UTSWCancerBio @UTSW_Surgery He had wonderful help from @TurleyLabGNE Mesothelial cell-derived antigen-presenting cancer-associated fibrobla... sciencedirect.com/science/ar…
18
18
5
87
Maddipati Lab retweeted
Our latest publication together with @SchneiderG_Dr lab in @EmboMolMed: Identification of treatment-induced vulnerabilities in pancreatic cancer patients using functional model systems embopress.org/doi/full/10.15… @MaxReichertMD @sfb1321 @TU_Muenchen 1/4
2
6
1
20
Maddipati Lab retweeted
From the February issue: #MYC levels regulate #metastatic heterogeneity in pancreatic adenocarcinoma by @MaddipatiLab, Ben Stanger et al. https://nitter.cf/t.co/vnQi3qv0vH @utswcancer @PennMedicine @PennCancer
1
5
1
15
Maddipati Lab retweeted
This weekend is my great-uncle's Centennial. His story is remarkable - born in a village of <100 people, mostly illiterate, dodging Partition, to @NobelPrize for cracking the genetic code & synthesizing the first artificial gene. dawn.com/news/1668120
117
561
88
2,747
Maddipati Lab retweeted
At the bar w @rmaddipa and @dellinger_lab at on rotation
1
2
15
Online now in @CD_AACR: #MYC levels regulate #metastatic heterogeneity in pancreatic adenocarcinoma by Ravikanth Maddipati, Ben Stanger, and colleagues @utswcancer @PennMedicine @PennCancer #pancreaticcancer cancerdiscovery.aacrjournals…
2
15
57